McKesson to Buy US Oncology for $2.16 billion

McKesson to Buy US Oncology for $2.16 billion

McKesson to Buy US Oncology for $2.16 billion

McKesson agreed to buy privately held US Oncology for $2.16 billion, including the assumption of $1.6 billion in debt, as the drug wholesaler and health-services company continues to expand in cancer services and distribution.

McKesson, the largest U.S. pharmaceuticals distributor by revenue, and US Oncology expect the deal to close by Dec. 31. Along with the assumed debt, the purchase price includes the acquisition of $150 million to $160 million in tax benefits, arising from certain net operating losses, that McKesson can use in the future. The companies expect substantially all of US Oncology’s debt will either be repaid or refinanced.

About Hunt Executive Search, Inc.

 

Hunt Executive Search, Inc. is the preeminent supplier of "A" Player human capital to the Consumer Products, Specialty Chemicals and Life Sciences industries.

 

Our clients include large publicly traded multi-nationals, mid-cap, family, and/or private equity-owned companies, wholesalers, and retailers. Our individual industry based practices include consumer goods companies in food and beverage, personal care, household products, over-the-counter pharmaceutical, consumer durables, and packaging services. Our specialty chemicals practice includes companies in coatings, plastics, industrials and adhesives. Our life sciences practice serves companies in bio-technology, medical device, generic, and brand name pharmaceuticals. Through retained executive search services for these clients we have placed executives in top-level positions at C- Suite General Management, Sales, Marketing, Product Supply, Manufacturing, R&D, Finance and Human Resources.

Website: http://www.huntsearch.com